Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal [Yahoo! Finance Canada]
Longboard Pharmaceuticals, Inc. (LBPH)
Company Research
Source: Yahoo! Finance Canada
Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc. in a $2.6 billion deal that boosts its drug pipeline for serious brain diseases. Most Read from Bloomberg The Danish pharmaceutical company is offering shareholders in the US company Longboard $60 per share in cash, in a transaction that has been unanimously approved by the boards of both companies, according to a statement. Shares of Lundbeck fell as much as 5.9% following the news. Longboard Pharmaceuticals rose as much as 52% in premarket trading on Monday. Lundbeck specializes in treatments for serious brain diseases and its proposed acquisition of Longboard will boost its development pipeline in neuro-rare conditions. Longboard's main drug in development is bexicaserin, a potential blockbuster treatment for patients suffering from rare and severe epilepsies, for which there are currently very few good treatments available. Bexicaserin is currently being tested on patients diagnosed with Dravet syndrome, Lenno
Show less
Read more
Impact Snapshot
Event Time:
LBPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LBPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LBPH alerts
High impacting Longboard Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
LBPH
News
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates B, LBPH, ZUO on Behalf of ShareholdersPR Newswire
- Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)Business Wire
- Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]Yahoo! Finance
- Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatesBusiness Wire
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, LBPH, ZUO on Behalf of ShareholdersPR Newswire
LBPH
Earnings
- 11/7/24 - Miss
LBPH
Sec Filings
- 12/2/24 - Form 4
- 12/2/24 - Form 4
- 12/2/24 - Form 4
- LBPH's page on the SEC website